NuCana PLC (NCNA)
1.27
-0.01
(-0.78%)
USD |
NASDAQ |
Nov 21, 16:00
1.28
+0.01
(+0.79%)
After-Hours: 20:00
NuCana Net Income (Quarterly): -8.826M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -8.826M |
March 31, 2024 | -8.673M |
December 31, 2023 | -9.507M |
September 30, 2023 | -8.479M |
June 30, 2023 | -6.776M |
March 31, 2023 | -9.562M |
December 31, 2022 | -17.87M |
September 30, 2022 | -5.329M |
June 30, 2022 | -4.893M |
March 31, 2022 | -11.27M |
December 31, 2021 | -18.39M |
September 30, 2021 | -11.09M |
June 30, 2021 | -12.70M |
March 31, 2021 | -13.46M |
December 31, 2020 | -16.18M |
Date | Value |
---|---|
September 30, 2020 | -10.85M |
June 30, 2020 | -7.516M |
March 31, 2020 | -5.083M |
December 31, 2019 | -9.930M |
September 30, 2019 | -4.777M |
June 30, 2019 | -5.745M |
March 31, 2019 | -6.979M |
December 31, 2018 | -4.647M |
September 30, 2018 | -3.277M |
June 30, 2018 | -1.796M |
March 31, 2018 | -8.891M |
December 31, 2017 | -6.695M |
September 30, 2017 | -17.88M |
June 30, 2017 | -3.513M |
March 31, 2017 | -2.028M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-18.39M
Minimum
Dec 2021
-4.893M
Maximum
Jun 2022
-10.34M
Average
-9.562M
Median
Mar 2023
Net Income (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | -17.62M |
Biodexa Pharmaceuticals PLC | -- |
Autolus Therapeutics PLC | -82.09M |
Mereo BioPharma Group PLC | -15.00M |
Bicycle Therapeutics PLC | -50.80M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 10.44M |
EPS Diluted (Quarterly) | -3.785 |
Enterprise Value | -11.87M |
Earnings Yield | -1.31K% |